Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 10—October 2009
Letter

Transmission of Varicella Vaccine Virus, Japan

Taketo OtsukaComments to Author , Yasuyuki Gomi, Naoki Inoue, and Makoto Uchiyama
Author affiliations: Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan (T. Otsuka, M. Uchiyama); Yurin Hospital, Fukushima, Japan (T. Otsuka); The Research Foundation for Microbial Diseases of Osaka University, Kagawa, Japan (Y. Gomi); Biken, Osaka, Japan (Y. Gomi); and National Institute of Infectious Diseases, Tokyo, Japan (N. Inoue)

Main Article

Figure

Sequence of gene 62 from patient with varicella from secondary transmission of Oka vaccine strain (vOka). The diagram at the top shows the structure of gene 62. Amino acid residues are numbered 1–1310 from the amino terminus to the carboxyl terminus. Vertical lines indicate the positions of 15-nt base differences between vOka (GenBank accession no. AB097932) and parental (pOka, accession no. AB097933) strains. The 15 boldface and broken lines show substitutions with and without amino acid (aa) a

Figure. Sequence of gene 62 from patient with varicella from secondary transmission of Oka vaccine strain (vOka). The diagram at the top shows the structure of gene 62. Amino acid residues are numbered 1–1310 from the amino terminus to the carboxyl terminus. Vertical lines indicate the positions of 15-nt base differences between vOka (GenBank accession no. AB097932) and parental (pOka, accession no. AB097933) strains. The 15 boldface and broken lines show substitutions with and without amino acid (aa) alterations, respectively. The charts show a comparison of the gene 62 sequences among vOka, pOka, Dumas (accession no. X04370), and the strain isolated from the secondary case-patient (accession no. AB497598). The black, white, and gray boxes denote pOka-type substitutions, vOka-type substitutions, and mixed-type substitutions (mixture of pOka and vOka nucleotides), respectively. NCR, noncoding region.

Main Article

Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external